The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancerHitomi Mori, Masafumi Nakamura|Oncotarget|2017Cited by 124
Influence of Estrogen Treatment On ESR1+ and ESR1- Cells In ER+ Breast Cancer: Insights From Single-Cell Analysis of Patient-Derived Xenograft ModelsHitomi Mori, Shiuan Chen|Research Square|2021Cited by 2